CVB

CURVEBEAM FPO [CVB]
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
Healthcare · ASX Small Cap
$0.0200 +11.1%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when CVB triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track CVB — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Trading above both moving averages — the trend is your friend here
  • Volume surging at 2.0x normal while price falls — heavy selling pressure
  • Knocking on the door of resistance — if it punches through, things could get interesting
  • Volume-price trend suggests distribution — sellers may be sneaking out while price holds
  • Critical cash runway (0.5 quarters)
  • Low P/S ratio (1.7x)
  • Revenue in sharp decline (-48%)
  • Near 52-week low (3% of range)
  • Micro-cap ($5-20M) - high risk
  • New substantial holder(s) (1)
  • CANSLIM S: Tight float (48%)
  • CANSLIM I: Institutional ownership (13%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 75% over the past year
  • Poor risk-adjusted returns — Sharpe of -1.6 means lots of volatility for not much reward
  • Altman Z-Score distress zone (-0.83 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.020)
  • Liquidity risk: 6 zero-volume days in last 20
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (1/9, low-confidence approx)
  • Deeply negative margins (-217%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -48% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-5.04%/day)

Expected next for CVB

28 Oct 2026Quarterly Activities ReportEstimated from past filings
Window: 21 Oct to 4 Nov
The last 5 moved CVB -1.6% on the day, on average — an observation, not a guide to what happens next.
29 Oct 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 22 Oct to 5 Nov
The last 5 moved CVB +4.2% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Change in substantial holding
NONE Change in substantial holding
NONE Application for quotation of securities - CVB
HIGH Becoming a substantial holder - Intellivision Holdings
Announcement tone +3pts

Recent ASX Announcements

2026-09-04 Change in substantial holding
2026-09-04 Change in substantial holding
2026-09-04 Becoming a substantial holder - Intellivision Holdings
2026-09-04 Application for quotation of securities - CVB
2026-09-04 Initial Director's Interest Notice - Dr Yu Peng

Key Metrics

$14.7M
Market Cap
114K
Avg Volume
2.0x
Vol Ratio
$0.02 — $0.14
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-59.9%
ROE
-217.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 48%
LLeader vs LaggardlaggardRS: -24
IInstitutional SponsorshippassInst: 13%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%GSS -10.3%
Compare:CVB vs NUZCVB vs IPDCVB vs HIQ
Share this analysis

Track CVB and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required